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Abstract
Objectives: Clostridioides difficile (C. diff) is a common but challenging infection both
financially and medically. Due to these difficulties, Clostridioides difficile infection (CDI)
caused by C. diff is a mandatory reportable disease in Nebraska and as such has been a priority
disease targeted by various disease control practices across many hospitals. All CDI laboratory
results are reported electronically through the Nebraska Electronic Disease Surveillance System
(NEDSS). However, capturing and conceptualizing the true burden of CDIs in Nebraska has not
been adequately accomplished since monitoring of CDIs began. The objective of this study is to
examine the trends of C. diff infections and related deaths in Nebraska from 2018-2020. In
addition, this study seeks to create a system to track CDIs in Nebraska through Geographic
Information System (GIS) mapping for better conceptualizing of CDI burden in the state.
Methods: To examine the burden of C. diff on Nebraska, descriptive epidemiology using lab
results reported in NEDSS from 2018-2020 and deaths reported with CDI association during the
same timespan were performed using the SAS analysis tool. Social vulnerability index (SVI)
provided by the Center for Disease Control and Prevention (CDC) was used to compare varying
counties and CDI counts. An interactive map using GIS was created to document and visualize
CDI prevalence of 2020 cases across the state of Nebraska.
Results: 8,334 CDI cases were recorded during the three-year span with case counts decreasing
36.5% from 2018-2020. The three-year prevalence rate for Nebraska was 459.07 per 100,000.
Yearly incidence rates decreased yearly from 181.56 to 130.42 per 100,000 over the three-year
span. 127 CDI-associated deaths were identified between 2018-2020 with increasing and
decreasing numbers and rates yearly. Demographic information including gender, age,
specimen/test type, race, ethnicity, and infection type of all 8,334 cases were recorded and
reported. In addition to demographics, over 600 medical facilities and nursing homes were
identified and stored into the state’s system for future identification of CDI case locating.
ANOVA and logistic regression analysis indicated that residents of high-risk SVI counties were
less likely to have a CDI than both moderate and low-risk SVI county residents. Lastly, an
interactive GIS map was created depicting 2020 case demographics and rates as well as case
numbers and rates by local health department (LHD) jurisdiction.
Conclusion: The overall burden of CDIs has been decreasing in Nebraska since 2018, however
death counts and rates have remained similar. While complications associated with CDIs due to
possible comorbidities may be harder to predict and prevent, this study has shown the positive
effect of antimicrobial stewardship on CDI prevalence statewide. Case demographics that have
been recorded as well as SVI analysis by this study have created a baseline understanding of atrisk populations in Nebraska and when combined with the GIS map can be used to locate CDI
outbreaks and decrease response time. Furthermore, the creation of the CDI GIS map has created
an efficient means of disease tracking and monitoring, and specifically for all common and
reportable healthcare-associated infections (HAIs) in Nebraska as it can be used as a
foundational template. Overall, this study was able to successfully describe the epidemiological
situation of Clostridioides difficile in Nebraska.
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ABBREVIATION
CDI
LTCF
SVI
NEDSS
NEDRS
CDC
EIP
ELR
GIS
PROC SQL
PCR
NAAT
EIA
MMWR
SAS
HIPAA
NDHHS
CFR
LHD
HAI
ASAP
ICAP
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DEFINITION
Clostridioides difficile infection
Long-term care facility
Social vulnerability index
Nebraska Electronic Disease Surveillance System
Nebraska Electronic Death Registration System
Centers for Disease Control and Prevention
Emerging Infections Program
Electronic reporting system
Geographical Information Systems
SAS procedure designed to specifically locate a CDI test
Polymerase chain reaction
Nucleic acid amplification test
Enzyme immunoassay
Morbidity and Mortality Weekly Report
Analytical software used to perform descriptive and statistical analysis
Health Insurance Portability and Accountability Act
Nebraska Department of Health and Human Services
Case-fatality rate
Local health department
Healthcare-acquired infection
Antimicrobial Stewardship Assessment and Promotion
Infection Control and Prevention
Office of the Chief Information Officer
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Background
Clostridioides difficile in Healthcare
Clostridioides difficile (C. diff) is a toxin-producing bacterium often
associated with colitis and severe diarrhea and is known to frequently reoccur after a first C. diff
infection (CDI). CDIs are most seen in nursing home residents and are a leading health care
associated infection in the United States.1 Studies have shown that CDIs make up 10-30% of
healthcare infections with asymptomatic colonization of C. diff seen in 2-3% in healthy
individuals and 10-25% of hospitalized patients.9-12 Hospitals are unique, complex environments
that continually change with the flow of people that reside and work within them. One important
aspect of C. diff is its ability to live on surfaces for up to five months suggesting that the hospital
environment is an important risk multiplier and place of transmission for C. diff.3 Consideration
that inpatients are not always static and may be granted liberalized movement permissions in
specific instances, it is not inconceivable that a patient can acquire a C. diff infection during their
stay.4,29 For those already infected with C. diff, viral shedding of spores can cause contamination
of surfaces, devices, and of healthcare workers’ bodies and attire creating reservoirs for C. diff
usually transmitted via the fecal-oral route.7,8 As such, a quarter of hospitalized patients will
contract a hospital-acquired infection indicating that controlling pathogens such as C. diff should
be a top priority.5,6
Clostridioides difficile in Long-Term Facilities
Another area of considerable CDI prevalence are long-term care facilities
(LTCFs). These types of facilities include assisted living facilities, skilled nursing facilities,
nursing homes, and rehabilitation centers. Common occurrences of CDIs can be correlated to
extended antibiotic usage, existing comorbidities, and age. Many residents of LTCFs are elderly
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and as such, antibiotic usage is higher amongst LTCF populations than the general population.
This in conjunction with older age and comorbidities make LTCFs a common reservoir of C.
diff. Due to these risk factors, incidence rates of CDIs have been reported to upwards of 50% of
residents in observed LTCFs.16-20 Also keeping into consideration that residents are living in
these facilities, spread of C. diff through interactions among residents via group gatherings and
events, and the lunch hall further increases the risk of transmission and CDIs. In addition, elderly
persons are more likely prone to complications if infected with C. diff. This unique dynamic
creates a distinctive priority to control the spread of C. diff in LTCFs.
Clostridioides difficile in the General Population
CDIs have demonstrated financial and clinical burdens on a national and state
level. One study found the average length of stay for CDI inpatient treatment has been
determined to be around 11 days and consequently, making CDIs an expensive infection with
average CDI-attributable costs around $42,316 per infection.2 Another study aimed specifically
at determining the burden of CDIs in Massachusetts found rates of CDIs to be 132.5 per 100,000
people in 2016 and a CDI mortality rate of 6.4 per 100,000 in 2014.13 Of the positive cases in the
study, 55.6% of positives were female, and incidence rates increased with age.13 These studies
signify an extreme burden on states around the country and warrants further investigation by the
states individually to understand their own C. diff burden. Yet the Massachusetts study is the
only published C. diff epidemiological study performed on a statewide level.13 Even then, this
study is not indicative of the Nebraska population and has incidence and mortality rate
calculations in separate years and over a one-year span. To understand Nebraska’s own unique
C. diff situation, a descriptive study must be undertaken that includes a multi-year timespan that
is also broken down yearly.
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Vulnerabilities and Clostridioides difficile
To study the effects of vulnerabilities on disease burden and catastrophic
events, the CDC has created a social vulnerability index (SVI) for counties in each state with the
last update being in 2016. This index is based on 15 social factors grouped into four categories
and is used to indicate vulnerability to a hazardous event on a 0 to 1 scale. The first category is
socioeconomic status that includes factors such as persons who are below the poverty line,
unemployed, have low income, or no high school diploma. The second category is household
composition and disability made up of factors such as persons 65 and older or 17 and younger,
persons with disabilities, and single-parent households. The third category is minority status and
language made up of two factors: persons who are part of a minority or speak English “less than
well”. The final category is housing and transportation made up of factors like multi-unit
structures, mobile homes, crowding, persons with no vehicle, and group quarters. A higher score
indicates a higher vulnerability.
Infection Control Programs for Clostridioides difficile
Various infection control programs have been put into place to control HAIs
including CDI. The most prominent practice attributable to high rates of CDI is inappropriate
prescribing and use of antimicrobials specifically, dosage, treatment duration, decision to
withhold or initiate antimicrobials, and regimens.22-27 This has led to microbial stewardship
programs aimed at improving antimicrobial practices to contain the spread of pathogens such as
C. diff. However, a systematic review has found that interventions placed on prescribing of
antimicrobials had little impact on both adherence to guidelines and decreasing the number of
antimicrobials being described in LTCFs.21 Hospitals have adapted to increasing C. diff
challenges through more microbial stewardship programs that have shown success in decreasing
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CDIs. Practices such as education of staff, reinforcing of proper handwashing and isolation
protocols, and monthly assessment and reviews of the practices have shown to markedly
decrease CDIs in the hospital setting.28 Such practices have been implemented statewide in
Nebraska. While stewardship program implementors understand that there is a C. diff issue in
Nebraska, they do not have a complete visual understanding of the true burden that CDIs have on
the state. Nor do they have adequate conceptualization of the current C. diff situation in
Nebraska. This lack of information does not provide appropriate feedback to these programs
regarding their efficacy in lowering the prevalence of CDIs. This project aims to give these
programs the tangible evidence to evaluate and adjust their protocols.
Use of Surveillance Data for Clostridioides difficile
The increased sophistication and advancement of the health care field has
allowed for better tracking and surveillance of diseases. Nebraska has a statewide reporting
system known as the Nebraska Electronic Disease Surveillance System (NEDSS) that allows for
labs to be electronically reported and accessible for health systems purposes. This system
provides the data to conduct studies that would otherwise be extremely limited to perform.
Through NEDSS, each lab performed is reported from every hospital in the state to allow
tracking and reporting of each mandatory disease. For C. diff specifically, NEDSS has been
recording labs performed since 2018 making NEDSS a primary source to analyze CDI data as
well as identifying clusters and outbreaks for immediate containment. As well as surveillance to
report disease incidences, death certificate data has become a more sophisticated means to help
track deaths associated with specific diseases. The Nebraska Electronic Death Registration
System (NEDRS) is one such database where these deaths and their causes are reported. Using
NEDSS in tandem with NEDRS we can describe the burden of CDIs in Nebraska.
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Every state health department has an electronic reporting system for
surveillance purposes just like the state of Nebraska. Through this surveillance data some state
health departments have also done their own tracking and monitoring of CDIs whether by their
own design or through the Center for Disease Control’s (CDC) Emerging Infections Program
(EIP). Through the EIP, the CDC has launched a C. diff surveillance program involving 10 state
health departments and several metropolitan areas residing within the same state. While this is
good for estimation of national population-based incidence and disease burden, this is not an
efficient means to describe Nebraska’s unique CDI burden. Furthermore, the states involved in
the EIP create yearly state CDI reports only based on the metropolitan areas involved within the
program. While this can paint an abstract picture of CDI burden, it does not adequately portray
the true burden in the entire state. This project aims to take CDI surveillance to the next level
with the use of Nebraska’s electronic reporting system (ELR) and the addition of mapping. By
analyzing the lab data and mapping the incidences of CDIs we will be able to better understand
disease control program efficacy, the burden of CDIs on the state, C. diff hotspots that require
more attention for targeted control measures, and potentially point towards CDI burden
associated with antimicrobial use/misuse within identified hotspots in Nebraska.
Using Mapping for Clostridioides difficile
One way to conceptualize the spatial clustering and transmission of disease
has come with Geographic Information System (GIS) techniques. While spatial analysis has been
widely used since the 1960s it has developed into a prominent epidemiological tool as seen
during the 2019 novel coronavirus pandemic.14,15 With the advancement of GIS mapping,
technologies such as this can provide higher insights and conceptualizations of disease burden in
epidemiological practices. GIS can be used to pinpoint clustered outbreaks, identify areas that
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are underserved, and predict growth and transmission of disease.14 The state of Nebraska has
created GIS mapping for the 2019 novel coronavirus pandemic statewide, but it has not used this
type of epidemiological practice to track other diseases and has only used GIS mapping for
listing the locations of the state’s biggest hospitals so the rural population can find the nearest to
their area of residence. GIS has many applicable uses including creating an easy-to-read story
map that allows the community and healthcare community to understand significant health
burdens that are affecting both their state and local area. COVID was the first major disease that
highlighted the applicability of GIS in epidemiology, but it is not the only major disease in the
world. C. diff is a significant problem and GIS should be used to create spatial mapping for
tracking purposes of CDI incidence in Nebraska.

Project Aim
This project seeks to create a baseline understanding of the current ongoing
C. diff situation in Nebraska. Using the state’s surveillance data, this study will be able to
calculate incidence rates, mortality rates, as well as identify the geographic areas most affected
with CDIs for targeted interventions. The study will also create an epidemiological description of
CDI cases by assessing exposure statuses within the affected CDI population. This will help gain
better insight into more at risk individuals in the state. Secondly, this project aims to determine
the efficacy of current stewardship programs. CDI laboratory results have been collected in
Nebraska’s surveillance data since 2018, so a longitudinal study of trends on CDIs can be
achieved. Moreover, this project aims to create a mapping system that can continuously be
updated to monitor CDI cases. The state health department contains the software to use GIS
mapping. By using this software, a map of the state with corresponding locations where CDI
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incidences have occurred will create a quick and easier concept to visualize the current C. diff
situation in Nebraska.

Methods
Study Design and Study Setting
This project is a retrospective, population-level, descriptive epidemiological
and spatial mapping study. Between the years 2018-2020, there have been over 8,000 CDI lab
tests performed. To perform this study, all CDI results during this timeframe were extracted from
NEDSS, placed into one excel file, and broken down into three separate excel files by year in
which the CDI occurred. The master Excel file was analyzed by the SAS analysis tool coded to
perform each descriptive task. Cleaning the data consisted of removing duplicate and incomplete
data.
Study Population
To study mortality, incidence, and prevalence of CDIs in Nebraska, cases
who have a positive laboratory test or had C. diff listed on their death certificate were the study
population with the 2010 census tract as the denominator to calculate these rates. For incidence
and prevalence calculations, all positive CDIs were included. For descriptive epidemiology
purposes in this project, cases with a positive CDI lab were the study population. Another aspect
that needed to be taken into consideration is that reoccurring episodes of CDI do occur. Per CDC
guidelines, positive labs between 2-8 weeks in the same case are considered recurrent episodes
and positive labs within two weeks are considered duplicate episodes. Our data cleaning
incorporated these rules implemented by the CDC. Any consecutive positive lab that was within
two weeks of the first positive lab was considered a duplicate and not a CDI. However, recurrent
positive labs two weeks or more after a first positive lab were considered an independent CDI.
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Data Sources
We used two sources of data: NEDSS and NEDRS. NEDSS is a real-time,
integrated electronic lab recording system used by the entire state’s healthcare system. NEDSS
contains every laboratory test, positive or negative, for each reportable disease in Nebraska. Each
event is recorded into the system for archiving and eventual analysis. NEDRS is similar to
NEDSS but with death certificate data. NEDRS reports contain the main cause of death in
addition to a secondary, and tertiary cause of death. C. diff listed in any order of cause of death
was considered for mortality data.
Data Extraction, Data Cleaning, and Variables
The ELR systems for Nebraska contain raw data of every lab that is
performed in Nebraska. This requires specific SAS coding to be able to extract C. diff specific
data. Using the PROC SQL command in SAS we were able to specifically target every CDI lab
that was performed between 2018 and 2020 and extract all those labs out of the NEDSS data
system. However, the data extracted was still raw and required significant data cleaning to
perform any analysis and descriptive epidemiology.
The ELR system comes directly from the hospitals that report the
information. The interaction between facilities that order the lab test and facilities that perform
the lab test are dynamic. Many facilities do not have the means to perform CDI labs and need
other facilities to perform the test for them. This creates a confusion on where the CDI has been
identified as some reporting facilities do not explicitly list which facility requested the CDI lab.
This in addition to different styles in reporting such as only reporting the ordering facility’s
address create a need to perform detective-like work by backtracking where the CDI occurred.
To do this, all ordering facilities and reporting facilities were organized, and the data cleaning
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process consisted of going through each ordering facility’s address, identifying which facility
that address belongs to, and unifying all ordering facilities in the SAS coding.
In addition, LTCFs are not included in the ELR systems. CDI has a higher
prevalence in the LTCF areas so creating a LTCF variable to document this was pertinent.
Typically, the LTCF is listed in the ordering facility so by using the same process as above we
were able to pick out LTCFs that ordered a CDI lab to create the new variable. In addition,
residents usually have the LTCF address listed as their own, using this data we were also able to
identify several LTCFs where a CDI occurred. Another variable that required cleaning was the
test type and specimen type. There are a substantial number of different names for a CDI test in
the ELR system but whether they were positive or negative was consistent. Test types were
organized and then categorized into four different categories: polymerase chain reaction
(PCR)/nucleic acid amplification test (NAAT), enzyme immunoassay (toxin) (EIA), culture, and
antigen. Specimen types were organized into unique but matching categories depending on the
specimen type. The other variables that were cleaned were county where the CDI occurred and
the local health department that has jurisdiction over which county. Once the county where the
CDI occurred was identified the health department that provides services to that county was then
able to be identified.
Variables such as specimen type, test performed, age, gender, race, infection
type, ethnicity, and Morbidity and Mortality Weekly Report (MMWR) week were recorded from
positive CDI labs for simple descriptive analysis. MMWR week is a 52-week timeframe
corresponding to the 52 weeks in a calendar year developed by the CDC. Rather than reporting
cases by the day, grouping cases within the same week allows for efficient grouping and easier
identifying of potential clustering of cases. Infection type categorized whether the CDI was
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classified as a community associated infection, meaning the CDI was acquired outside a medical
facility or clinic, or a healthcare associated infection meaning that the CDI was acquired in a
medical facility. Gender, age, race, ethnicity, infection type, and MMWR week did not require
much to any cleaning.
Study Analysis and Descriptive Study
CDI incidence and mortality rates for each year were calculated using the
ELR surveillance data. Since this study does have a timeframe of three years, a three-year
prevalence and crude mortality rate were calculated in addition to the yearly rates. Yearly
incidence rates were calculated by dividing the number of positive CDI cases by the state of
Nebraska’s population according to the 2010 census and multiplied by 100,000 as incidence rates
are reported per 100,000 people usually. The three-year prevalence was calculated by the total
positive CDIs over the three years and divided by Nebraska’s population. Mortality rates were
calculated similarly to the incidence and prevalence rates but instead by taking the number of
CDI associated deaths and dividing by the state population and reporting per 100,000. The yearly
rates were then compared to the national rates as well as between each year to show trend
direction.
Since C. diff has a more profound affect on the older population, an ageadjusted mortality rate was calculated among three different age categories: 0-5, 6-64, and 65+.
People between the ages 0 and 5 make up 6.7% of Nebraska’s population, 6 to 64 make up
77.2%, and 65+ make up 16.1% of Nebraska’s population according to census bureau data.
These percentages were used to calculate the denominator in our age-adjusted mortality rates for
each year and the three-year study span. Additionally, case-fatality rates were also calculated
yearly and over the three-year span by dividing the number of CDI deaths by the number of
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positive cases and recorded as a percentage. Key simple descriptive information that was
analyzed through SAS included basic counts, means, and percentage make-up of gender, race,
ethnicity, age, sample type, test performed, infection type, and MMWR week.
To study vulnerabilities and CDI incidence, Nebraska counties were given a
SVI score based on the CDC SVI scale and placed into categories of three different
vulnerabilities: low (≤ 0.33), moderate (0.34-0.67), and high (≥ 0.68). Once gathered and
grouped accordingly, the overall number of CDI labs, both positive and negative, of the three
SVI categories were then compared using ANOVA testing and logistic regression in SAS.
Cases, deaths, mortality, incidence, and prevalence rates where then broken
down further by local health department (LHD). Each case number for each health department is
the culmination of all the cases recorded from each county that the local health department has
jurisdiction over. All rates were calculated the same as the state rates except the population of
each health departments jurisdiction was used as the denominator instead of the state population.
All local health department populations were found by calculating the sum of each county they
cover according to census information.
GIS Mapping
2020 CDI data was used as the baseline data for the GIS map. A geographical
map of Nebraska separated by LHD borders served as the template with which interactive
information was entered. From there, case numbers were added up by each county within the
same LHD and displayed within each local health department’s unique window when clicked on.
Each health department jurisdiction was shaded based on case numbers. In addition, each health
department’s unique incidence and mortality rates were placed along with case counts within
their jurisdiction’s window that could be viewed when the user clicks on the jurisdiction of their
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choice. Sections displaying the descriptive epidemiology of positive CDIs were placed next to
the GIS map as well as the overall 2020 CDI situation to give viewers more insight. Lastly, the
national rates were placed within the overall section for reference to Nebraska’s CDI situation
when compared nationally. All descriptive epidemiology variables placed in the GIS map were
graphed based on overall numbers and percentages using bar and pie graphs, respectively.
Reporting Guidelines of the GIS Map
The GIS map and all results included were reported according to CDC,
Health Insurance Portability and Accountability Act (HIPAA), and Nebraska Department of
Health and Human Services (NDHHS) reporting guidelines and regulations. This included
reporting CDIs by LHD jurisdiction rather than county, displaying case numbers with a certain
minimum required, displaying reliable results that were gathered accurately with minimal
missing data, and using the insignia and colors associated with NDHHS.

Results
The overall number of positive CDIs identified in the three-year span was
8,334 (95.63%) of 8,715 total CDI tests being administered. CDI counts were 3,296 in 2018,
2,944 in 2019, and 2,094 in 2020. 4,844 (58.12%) of all cases were female and 3,480 (41.76%)
were male (table 1). 10 (0.12%) case were unknown for gender. Caucasian race made up 56.10%
(4,675) of cases, 39.56% (3,297) were unknown, 3.06% (255) African American, 0.55% (46)
other, 0.41% (34) American Indian, 0.30% (25) Asian, and 0.02% (2) Native Hawaiian. NonHispanic ethnicity made up 56.82% (4,735) of CDIs, 41.10% (3,425) unknown, and 2.09% (174)
were of Hispanic ethnicity (table 1). PCR/NAAT tests made up 65.14% (5,429) of CDI tests,
enzyme immunoassay toxin tests made up 32.45% (2,704) of tests. Antigen tests accounted for
2.15% (179) of tests and culture tests made up 0.24% (20) of tests (table 1). Of positive CDIs,
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stool samples were 98.72% (8,227), unknown samples 0.95% (79), body structure and microbial
isolate samples 0.10% (8), urine samples 0.08% (7), blood samples 0.04% (3), and peritoneal
fluid and abscess samples were 0.01% (1) of all collected specimens (table 1). Of all positive
CDIs, 75.89% (6,325) were considered community-acquired infections, 14.91% (1,243) were
considered hospital-acquired infections, and 9.19% (766) were unknown (table 1).
CDIs were also broken down by age groups (table 1). The median age of all
CDIs was 65 years old (Range: 0-104 years) with the most common age (mode) being 71 years
old (table 5). Of 8,334 CDIs, cases aged between 65-74 accounted for most cases at 21.53%
(1,794). Cases aged between 75-84 were 17.06% (1,422), 16.02% (1,335) were between 55-64,
people 85+ accounted for 11.77% (981), 45-54 were 8.84% (737), 0-19 were 8.72% (727), 20-34
were 7.74% (645), and 35-44 were 7.49% (624). Unknown ages accounted for 0.83% (69) of all
positive CDIs. Age-adjusted case-fatality rates were calculated for three different age groups as
well (table 6). The CFR for age group 65+ was 36.95 per 100,000, 1.36 per 100,000 for ages 664, and 0.00 for ages 0-5.
The overall number of CDI-associated deaths were 127. 2018 recorded the
highest number of CDI associated deaths with 53 followed by 2020 with 45 and 2019 with 29
deaths. The overall prevalence between 2018 and 2020 was calculated at 459.07 per 100,000
people. Incidence rates for 2018, 2019, and 2020 were 205.28, 183.36, and 130.42 with mortality
rates of 3.30, 1.81, and 2.80 per 100,000, respectively. Overall mortality rate was calculated at
7.11 per 100,000 with an overall case-fatality rate (CFR) of 1.55%. The CFR was calculated at
1.61% in 2018, 0.99% in 2019, and 2.15% in 2020.
CDIs were then broken down by LHD jurisdiction (tables 2-5). Median case
count for CDIs in LHDs was 84 (Range: 6 – 820) in 2018, 87 (14 – 675) in 2019, and 72 (7 –
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491) in 2020. Median incidence rates were 178.52 per 100,000 (28.56 – 308.36) in 2018, 168.67
per 100,000 (14.28 – 427.37) in 2019, and 112.52 per 100,000 (33.32 – 321.88) in 2020. Median
mortality rates were calculated at 2.71 per 100,000 (0.00 – 8.65) in 2018, 0.68 per 100,000 (0.00
– 7.25) in 2019, and 2.21 per 100,000 (0.00 – 9.90) in 2020. Median CFR were 1.52% (0.00% 10.53%) in 2018, 0.42% (0.00% - 7.14%) in 2019, and 1.58% (0.00% - 14.29%) in 2020.
CDI statistics by LHD describe Nebraska’s CDI situation regionally. The
number of LHDs with incidence rates over 100 has decreased yearly since 2018. However, six
LHDs have seen increased incidence rates since 2018 with the highest increase occurring at
Public Health Solutions health department with a 31.7% increase. Central District health
department saw the highest decrease in rate at 76.9% and five total LHDs saw their rates
decrease by half since 2018. Three LHDs saw a rise in incidence rates from 2018-2019 that were
followed by a decrease in rates in 2020. Three LHDs saw the opposite with decreasing rates from
2018-2019 followed by an increase in 2020. Over the course of entire study, Panhandle health
department jurisdiction observed the highest prevalence at 699.07 while Dakota health
department had the lowest prevalence at 76.17.
The ANOVA analysis calculated a p-value less than 0.001 indicating a
difference among one or more of the SVI groups (table 7). From there, the logistic regression
model indicated that persons in high risk SVI counties were less likely to have a CDI case than
persons in low risk SVI counties (p<.0001), persons in high SVI counties were also less likely to
have a CDI than persons in moderate risk SVI counties (p<.0001), and persons in low risk SVI
counties were less likely to have a CDI than persons in moderate risk SVI counties (p=0.0437).
Specifically, the odds that persons in moderate risk SVI counties have a CDI is 8.3 [5.4,12.8]
times higher than high risk SVI county residents. The odds that persons in low risk SVI counties
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have a CDI are 5.4 [4.3,6.7] times higher than moderate risk SVI county residents. The odds that
persons in moderate risk SVI counties have a CDI are 1.5 [1.0,2.4] times higher than low risk
SVI county residents (table 8).
The GIS map was created using 2020 CDI data and with an ultra-link. The
link was placed inside the healthcare-associated infection (HAI) Data and Reports section inside
the NDHHS HAI website displayed as “Clostridioides Difficile Cases in Nebraska 2020”. Upon
clicking the link, users are brought to a map of Nebraska shaded different colors. The map of
Nebraska is outlined by local health department jurisdictions with county borders inside the
jurisdictional borders (figure 1). LHD jurisdictions are shaded according to the total CDI counts
within their borders; light yellow implies lower case counts and darker blue implies higher case
counts. Each LHD section can be clicked on to view their specific case number, incidence rate,
mortality rate, and case-fatality rate (figure 2). It is important to note that the numbers are LHD
numbers and not county numbers. In the top left corner of the map, several tabs were created to
display certain aspects of the 2020 CDI data. The overall tab depicts the total positive CDI labs,
the total negative CDI labs, total people tested, total deaths, state and national incidence and
mortality rates, and the age-adjusted mortality rate for Nebraska (figure 3). In order, the other
demographic data displayed within separate tabs were positive CDIs in 2020 by age, gender, test
type, specimen type, infection type and CDIs by MMWR week (figures 4-9). Each demographic
was shown as a percentage with a pie graph and overall number with a bar graph.

Discussion
Overall case counts decreased yearly between 2018 and 2020; 36.5% overall
from 2018 to 2020. The Nebraska medicine and NDHHS antimicrobial stewardship assessment
and promotion (ASAP) coalition started in 2017 as a pilot and in 2018 engaged many facilities
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across the state in coaching them to develop their own stewardship programs. Since 2018
antimicrobial stewardship statewide summits have been held yearly and the focus shifted to
reducing CDIs in Nebraska in 2019. The focus has been on messaging and education on
promoting appropriate antibiotic use in various health care settings. The overall decline in CDI
incidence is indicative of the positive effect infection control and prevention (ICAP) programs
have had. The national CDI incidence rate per the CDC is 130.1 per 100,000. Although, the CDI
incidence rates were above the national average, the incidence rate in 2020 was equal to the
national average further highlighting the positive effects of ICAP programs. The varying
increase and decrease in mortality rates are more difficult to explain and are as unique as the
persons who developed complications to CDIs. However, when looking at the age-adjusted
mortality rates it does not come as a surprise that the senior population develops complications to
CDIs more so than the younger populations. Nevertheless, Nebraska’s CDI mortality rate of 2.8
was also lower than the national average of 3.9 even though it rose from the preceding year.
The age demographics and the MMWR numbers indicate that there is no
seasonal preference, but that CDI appears more prominent in the elderly population. This is not
surprising to see but more so only confirms studies and reports indicating higher CDI prevalence
in the older population. Furthermore, CDIs typically occur due to prescription overuse. Do to
that fact and that older populations are commonly on daily medications it is not surprising to see
the numbers higher in the older populations. Likewise, females tend to have longer lifespans than
males. This indicates that the elderly population would have a more female prominence and
makes sense when considering that the female gender made up 58.12% of the positive CDI
cases. For future studies, it may be worthwhile to further breakdown the age groups to find
possible risk factors and exposures for their CDI outcomes. Lastly, Nebraska is predominately
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Caucasian, so it does not come as a surprise to see more than half of positive CDIs affecting this
specific population the most as well as those of non-Hispanic ethnicity. However, the unknown
percentage is relatively high and highlights a sizable void in lab reporting. In the future, even if
these high unknown issues are due to patients not reporting, it is important to reach out to
reporting facilities to discuss the importance of clear and concise reporting to understand CDIs
within certain racial and ethnic populations.
C. diff typically affects the colon. Since a CDI typically constitutes as an
infection of the colon it would be assumed a sample from the colon area would be the typical
sample to detect C. diff. Therefore, a stool sample would be the logical choice to run a CDI lab
test on. Our results indicate that to truly be the case with almost all positive tests using a stool
sample. Our results have also surprisingly shown that other structures, although uncommon, can
also be used for C. diff detection. This creates a possible case study situation for all positive CDI
labs that did not use a stool specimen to understand symptoms exhibited by the patient and the
potential reasonings the provider opted for a sample other than a stool sample.
In the world of modern medicine, it is preferable to be able to diagnose and
treat the patient as fast as possible before complications develop. While culture tests for C. diff
detection are the gold standard, they are usually labor intensive, require very careful quality
control, often associated with false-positive results, and results usually take the longest to
achieve. These reasons are usually why providers would opt for an EIA toxin, PCR/NAAT, or
antigen test. However, while antigen tests are the most rapid test, they are not confirmatory tests
and usually need to be combined with either a toxin or PCR/NAAT test. The results confirm that
providers would prefer PCR/NAAT or toxin test over an antigen or culture test due to their cons.
Both PCR/NAAT and toxin tests are rapid results, however, toxin tests are typically a cheaper
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testing approach as opposed to PCR/NAAT testing but they are not as specific. Therefore,
deciding on which test to perform between toxin and PCR/NAAT would appear to come down to
provider preference. With PCR/NAAT tests accounting for 65.14% of total positive CDI tests, it
becomes clearer that providers would prefer to have a test with high specificity and sensitivity
performed at a higher cost.
Hospital acquired CDIs account for around 24 percent of all CDI infections.7
Our results may indicate that to be the case for Nebraska as well, but they also indicate that
hospital acquired CDIs may be less than 24 percent of all CDI case in Nebraska. Considering
that C. diff is commonly viewed as a hospital acquired pathogen, it is preferable that future
reporting requires strict adherence to report how the CDI was acquired.
Grouping counties by SVI and comparing their cumulative case numbers was
performed as an attempt to begin understanding potential exposures that could be correlated with
getting a CDI. The ANOVA test revealed that at least one of the SVI groups has a significantly
higher or lower CDI caseload. However, it does not reveal which one of these groups is
significantly different. The logistic regression analysis was performed to determine which group
or if all the groups were different than each other, and it provided interesting results. High SVI
counties accounted for 72.7% of all positive CDI cases during the three-year span, yet the odds
of getting a CDI were lower than both moderate and low risk SVI counties. Considering that all
the big metropolitan areas are in high SVI counties and therefore high SVI counties have a
considerably higher population and thus lower incidence rates of CDIs could explain why the
odds of getting a CDI are lower. However, that does not provide adequate explanation. Upon
examination of the model fit statistics, the AIC, SC, and -2 Log L were all above 3,000
suggesting that the model is not a very good fit at determining CDI outcomes. This suggestion
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also indicates the possibility that certain social determinants and barriers within the index may
not be adequate variables to help predict the possibility of a CDI outcome. Furthermore, SVI is
an overgeneralization of a county and not truly indicative of the people who reside within its
borders. To be able to understand CDI risks and exposures it is suggested to use other
determinants or geocoding factors such as zip codes or even proximity to a medical hospital to
discover any that may exist.
Creation of the GIS map required clean, accurate data with relatively low
unknown percentages. Without complete material organized properly, GIS mapping of CDIs
would not be considered. Furthermore, organizing the material that would be included within the
map needed to include both valuable knowledge that could provide insight into the CDI situation
in Nebraska and not give out any information that could lead to identification of any person who
had either acquired a CDI or died from a CDI. The technology needed to create a GIS map is
through the office of the chief information officer (OCIO) at the state department. Thorough
communication is needed to establish and create the guidelines and parameters necessary to
convey the message the map is trying to send to anyone who views it.
At the state and federal level, only COVID has been deemed an exception to
all the GIS reporting guidelines. Using LHD borders and displaying rates and counts by LHD is
one such guideline implemented by the state. This guideline was made with regards to HIPPA.
Counties are small enough in population in Nebraska and CDIs can occur at a small enough rate
that can make an individual identifiable. For instance, if a county had just one single CDI during
the entire year it would make identifying that individual easier. Reporting by LHD alleviates that
potential issue because all cases and rates are reported as a summation of all the counties that lie
in their jurisdictions. But this does not completely get rid of the issue. Some LHDs like Douglas,
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Lincoln/Lancaster, and Dakota LHD govern only one county and even some of the more rural
LHD jurisdictions are capable of reporting low CDI numbers. Even though the populations
within Douglas and Lincoln/Lancaster LHD are large enough to make identification of those
who obtain a CDI more difficult, a minimum required number of five is required to report the
specific number of cases and deaths. Anything less than five requires censorship per state
guidelines.
Reporting numbers as a rate makes identification more difficult and also
standardizes the burden of CDIs when trying to compare LHDs or geographical locations to
another. Reporting incidence and mortality rates as well as overall counts by LHD in addition to
scaling their case numbers by color paints a good story to help users visualize what the burden of
CDIs are in each specific area. Also, as stated above, creation of the GIS map requires clean,
accurate data, with a low percentage of unknowns. The two categories of data that did not meet
this requirement were the ethnicity and race categories. Until these variables can reach a lower
unknown percentage, they will remain off the GIS map. In addition, even though over 600
facilities have been identified they must be left off the GIS dashboard as well as of now. Like
low case numbers by county, some facilities report low numbers as well. Also, even though the
SAS coding has three years’ worth of reporting to be able to categorize and extract the ordering
facility, the coding still needs more refining and confirmation of accuracy by further developing
the code over the next several years. This will help to ensure accuracy and increase confidence to
share facility specific data. With all this in mind however, there are plans to develop an internal
dashboard to be used by the state only. This dashboard can contain any amount of information
desired including facility, race, and ethnicity. This provides the means of auditing the map for
ways to improve what the external map already created can become.
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Putting a map into production does not happen until the map has shown the
ability to function as a test website first. Once the map was created and shown to function
correctly as a test website, creating a link, and placing it within the NDHHS website to access
the map needed coordination with the state web team. The website team makes sure that the map
is created according to the state’s reporting guidelines in addition to the correct state colors and
ensuring the state department’s logo was displayed correctly. Deciding where the link was placed
was up to the healthcare-associated infections epidemiology team. Once all these parameters
were met, the map went into full production and was then able to be viewed by anyone who
found it on the NDHHS website.
The map is designed to tell several different stories. The first story is the
overall burden of CDIs on the state of Nebraska and how it compares nationally. There are very
few states that do external reporting on their CDI burdens and even then, the other state
departments that do report are the ones involved in the CDC’s EIP program and only report the
numbers of their metropolitan city involved. For future purposes, it is the hope that there will be
more accessible reports like Nebraska’s that can be incorporated into the map to compare where
Nebraska stands on the CDI scale. The next stories are about who have been affected by CDIs
and how CDIs have been determined. These stories are intended to enhance and promote further
understanding of CDIs.
The final stories, and most important stories, are the unique CDI situations of
each LHD embedded within the map of the state. Any persons interested in C. diff can click on
the map and discover that the Panhandle Health Department jurisdiction has the highest CDI rate
in Nebraska and Dakota Health Department has the lowest rate. They could also see that Loup
Basin Health Department has the highest mortality rate and a few LHDs do not have any
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recorded deaths. LHD information was integral in the map creation as this allows the LHDs, and
medical personnel that reside within them, the ability to determine their specific CDI situation.
This in return could drive change by allowing LHDs to do their own investigating and decrease
their specific rates. Eventual integration of facilities will further boost efforts in decreasing the
CDI burden.

Conclusion
Clostridioides difficile is a mandatory reportable disease in the state of
Nebraska, however epidemiological knowledge regarding CDI burden has been limited. This has
left facilities and infection control and prevention teams with little understanding about current
conditions and suppressed any progress that has been spent towards alleviating CDI conditions.
This also obstructed in any attempts by antibiotic stewardship programs to identify where, why,
and how interventions can be applied to any facility, clinic, or physician to eliminate needless
prescription ordering. To better understand and create a sense of direction in targeting areas
affected by C. diff, descriptive epidemiology and epidemiological mapping were necessary to
understand the C. diff situation in Nebraska.
This project created a baseline understanding on the current and previous
conditions of Clostridioides difficile in Nebraska. As a result of this study, we can identify over
600 medical facilities and nursing homes across the state as well as cases by LHD that can
continually be used to update the C. diff situation into a GIS story map. Through GIS mapping
conceptualizing the areas hit most by C. diff are more readily available to ICAP teams thus
decreasing the time to outbreak response. The GIS mapping is also a means for each LHD to
view the current C. diff areas in their areas as well as the burden C. diff has on their areas. In
addition, calculations in trends of incidence have visually demonstrated the successful attempts

26
at mitigating the CDI issue in the state showing a continued decrease in over the last three years.
While there have been studies on the epidemiology of C. diff on a statewide scale, those studies
did not take it further to include GIS mapping to visualize current C. diff burden in the state.
While this is a good reactive approach to disease studying, our study takes it further to provide a
more proactive approach in disease monitoring and prevention as the map can be updated
regularly. This approach is key to improvement of public health effectiveness in the communities
it serves.
There are a few limitations to the study. The first limitation regards data
quality, collection, and reporting. Facility reporting is not explicit and requires detailed coding to
dig up the true facility where the CDI occurred. Having reporting that is clear and concise allows
for better data quality and thus more accurate data. While the SAS coding was specifically
tailored to 2018, 2019, and 2020 data to ensure accuracy for these years specifically, the coding
will need to continually be monitored for following years to ensure data quality is accurate.
Furthermore, this study highlighted the limitations in understanding race and ethnicities effect on
CDIs. This is another example ushering the need for better reporting quality into the ELR
system. There are limitations regarding SVI and its potential correlation with CDIs. SVI is a
generalization of each county and not specifically indicative of different communities within the
area. Finding and using a more specific means such as zip code could provide for a better method
to study CDIs on the population. In addition, this would create a better fitting model to
understand and better determine vulnerabilities and their correlation with CDIs.
In addition, the possible effect and interaction between COVID and C. diff is
a potential limitation to this study. While it is known that both affect older aged people and have
diarrhea as a symptom, it is not known if COVID testing has led to decreases, or even increases,
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in C. diff testing and detection. CDI numbers are lower in 2020, but correlation between COVID
and C. diff is a further topic for discussion. However, moving forward from 2020, the GIS map
created during this study will continue to serve as a point of reference for facilities and ICAP
teams in the struggle with C. diff.
The overall focus on CDIs and hospital-acquired infections has increased
dramatically within the last several years. With the map produced in this study, the CDI
containment movement can now move with more precise actions targeted in specific areas hit by
C. diff to mitigate both its spread and burden on the state of Nebraska. In addition, this study has
opened the door for GIS mapping’s ability to support the public health movement of more
innovative disease tracking of hospital-acquired infections leading to more comprehensive ways
public health can survey disease burden across the entire state.
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Appendix A

Table 1. CDI demographics by gender, age group, race, ethnicity, test type, specimen source, and infection type 2018-2020.
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Appendix B

Table 2. CDIs by year with LHDs.

Table 3. CDI prevalence and incidence rates by year with LHDs.
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Table 4. CDI mortality rates by year with LHDs.

Table 5. CDI CFR rates by year with LHDs.
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Appendix C

Table 6. Age-adjusted CFR. Population percentage based on 2010 census data.

Table 7. ANOVA analysis on SVI groups per case number.

Table 8. Logistic regression analysis on SVI groups per case number.
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Appendix D

Figure 1. GIS map of 2020 CDI data.

Figure 2. GIS map of 2020 CDI data with overall data
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Figure 3. GIS map of 2020 CDI data displaying LHD data.

Figure 4. GIS map of 2020 CDI data displaying gender demographics.
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Figure 5. GIS map of 2020 CDI data displaying test type demographics.

Figure 6. GIS map of 2020 CDI data displaying specimen type demographics.
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Figure 7. GIS map of 2020 CDI data displaying infection type demographics.

Figure 8. GIS map of 2020 CDI data displaying case by MMWR data.
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Figure 9. GIS map of 2020 CDI data displaying age demographics.
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Storm Keffer
College of Public Health, Epidemiology Department
University of Nebraska Medical Center

Storm is a student at the College of Public Health concentrating in the field of
Epidemiology. He graduated from Doane University in 2017 with a degree in
biochemistry where he also took a beginner’s course on public health just so he could
graduate. After graduating he took a year off from school and worked in the human
genetics lab as a cytogenetic technologist at UNMC. In 2018, he applied to the
epidemiology program at the College of Public Health and has loved that decision since.
His interests including antibiotic resistance, infectious diseases, emerging diseases,
emergency preparedness, biocontainment, and bioterrorism. He has worked with the MS
clinic at UNMC to address health disparities for those with MS, worked on helping with
development of a Nebraska pandemic plan, and is a founding member for the student One
Health group at UNMC. He hopes to pursue a PhD once he obtains his MPH degree.
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with a diligent, responsive, and resourceful nature.
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o 531-530-7407 c 402-547-1008
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Education
MPH (Epidemiology), University of Nebraska Medical Center
BS (Biochemistry), Doane University
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2012-17

Academic Projects and Achievements
APEX, Department of Neurological Sciences – Multiple Sclerosis (MS) Clinic, University of
Nebraska Medical Center
May 2020 to August 2020
Specific duties and accomplishments
o Attended clinical sessions with MS providers. Sessions included house
calls, transdisciplinary clinic and community partnership program, and
telemedicine visits
o Identified and created data repository to arrive at estimates of the
number of individuals with MS and significant disabilities
o Contributed to the strategic planning of identifying stakeholders who are
interested in the field of disability/disparities/social determinates, and
health care
o Assisted in creating awareness in the community for individuals with
MS
o Developed a policy brief that highlights keep issues faced by those with
MS as well as solutions
Capstone, Nebraska Department of Health and Human Services, Public Health Division
August 2020 to May 2021
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Specific duties and accomplishments
o Defined the epidemiology of Clostridioides difficile in Nebraska
between 2018-2020
o Described the demographical data of all Clostridium difficile infection
(CDI) cases in Nebraska
o Determined the efficacy of Nebraska’s antimicrobial stewardship
programs by assessing trend data between 2018-2020
o Attempted to discover other potential at-risk populations outside the
healthcare and long-term care facility realms by using the social
vulnerability index (SVI)
o Created a geographic information system (GIS) map designed to convey
the most up-to-date CDI information for future monitoring. This map
will be used as a template for all healthcare-acquired diseases (HAIs) in
Nebraska
o Created a SAS code used as a template to identify all (HAIs)
o Identified over 600 medical facilities, nursing homes, rehabilitation
centers, assisted living facilities, and skilled nursing facilities in the state
of Nebraska
o Created a foundational solution to enhance outbreak response and
display real time disease information
Appointments and Positions
Heath Surveillance Specialist, Nebraska Department of Health and Human Services
(NDHHS), Public Health Division
June 2020 to present
NDHHS Public Health is the state appoint division to assist and help all Nebraskans in
public health matters across the state. This division is responsible for preventive and
community health programs and services. It is also responsible for the regulation and
licensure of health-related professions and occupations, as well as the regulation and
licensure of health care facilities and services.
Specific duties and accomplishments
o Contact tracing team lead and liaison between the state department,
Douglas County Health Department (DCHD), and third-party contact
tracing vendor Professional Research Consulting (PRC)
o Assisted in creation and training of contract tracing techniques and SOPs
with third-party contact vendors
o Developed an efficient method to record COVID hospitalizations
Epidemiological work in COVID hospitalization outcomes still ongoing
o Assisted in establishing new contact tracing software move from
REDcap to SalesForce
Subject Matter Expert (volunteer), Pandemic Planning Leadership Team, University of Nebraska
Medical Center
January 2020 to June 2020
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The Pandemic Planning Leadership Team was created by UNMC to oversee several
committees in the preparation of the impending COVID pandemic for both UNMC and
the state of Nebraska
Specific duties and accomplishments
o Revised the UNMC Pandemic Plan tailored specifically to COVID
o Served each committee on the team as a point of information for them to
adequately plan for COVID pandemic
o Created basic “best guess” epidemiology of COVID during Wuhan
outbreak to determine future burden on the state of Nebraska
o Calculated potential future burn rates of personal protective equipment
(PPE) and inventory
o Assisted in creation of personnel tracker and morgue reports
o Developed predicted UNMC hospital resource usage and predicted
COVID outcomes for Douglas County
o Developed state, UNMC, and various other hospital COVID caseload and
death predictions using gamma distribution. Depicted the role of
mitigation or “flattening the curve” of COVID on hospital surge capacity
and its importance in Nebraska
o Assisted in information gathering in the creation of UNMC’s COVID
dashboard
o Assisted in sample collection, literature review, and data management of
project in determining COVID in wastewater.
o Participated in presentations demonstrating basic knowledge of COVID
and diseases in addition to potential burdens of COVID on the community
of Nebraska
Cytogenetic Technologist, Munroe-Meyer Human Genetics Lab (HGL), University of Nebraska
Medical Center
July 2017 to February 2020
UNMC HGL combines comprehensive genetic testing with personalized clinical
consultation to provide the very best in genetic medicine to every client and patient
Specific duties and accomplishments
o Perform tissue culture & DNA extraction on human samples
o Prepare G-banded slides and hybridize DNA probes for analysis of
genetic disorders
o Use bright field and fluorescent microscopes with a computer imaging
system to prepare karyotypes and digitized fluorescence in situ
hybridized (FISH) images
o Interpret and summarize karyotypes and FISH results and write
cytogenetic and molecular cytogenetic reports for patient diagnostic
purposes
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o Developed procedural use of ROBOSEP for lymph node and bone
marrow core samples

o Developed more efficient way of freezing patient samples. Decreasing
time to perform task exponentially
Interventionalist (volunteer), Occupational/Physical Therapy Department, University of
Nebraska Medical Center
June 2015 to August 2015
Specific duties and accomplishments
o Communicate, participate in activities that incorporated the Hand Arm
Bimanual Intensive Therapy (HABIT) guidelines, and monitor progress in
children with Hemiplegic Cerebral Palsy
o Exhibited progress in patient motor functioning in both fine and gross
motor skills

